- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02807935
The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal Micro-structure
The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal
The purpose of our current series of studies is to evaluate different glaucoma treatments in vivo effect on the conventional outflow pathway, and specifically on the Schlemm's canal (SC) anatomy using Enhanced Depth Imaging (EDI)-optical coherence tomography (OCT) . The images will be taken as part of the patients routine medical follow up (before starting the treatment, and 1,4 and 12 weeks afterwards) diameter, cross-sectional area and volume will be measured using commercially available 3-dimensional reconstruction.
The series of studies will be divided into 3 branches, each branch contains different treatments.For each treatment different patients will be recruited.
The branches are as following-
The surgical branch-
- Before and after trabeculotomy
- Before and after cataract surgery
- Before and after vitrectomy surgery
- Before and after XEN™ Gel Stent implant
The pharmacological branch-
- Before and during the treatment with prostaglandins analogs
- Before and during the treatment with alpha blockers
- Before and during the treatment with beta blockers
- Before and during the treatment with carbonic anhydrase inhibitor
The laser branch-
- Before and after trabeculoplasty
- Before and after laser iridotomy
- Before and after yag capsulotomy laser
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Meira Fogel-Levin, M.D
- Phone Number: 972-523249402
- Email: mirifoglevin@gmail.com
Study Locations
-
-
-
Ramat-Gan, Israel
- Sheba Medical Center
-
Contact:
- miri fogel levin, m.d
- Email: mirifoglevin@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female of any race, at least 18 years of age.
- Has provided verbal and written informed consent.
- Able and willing to follow instructions, including participation in all study assessments and visits.
- Has been referred to one of the treatments mentioned
Exclusion Criteria:
- Has history of ocular conditions that may affect the SC structure (e.g., ocular neovascularization, anterior segment congenital anomalies)
- Subject uncooperativeness that restricts adequate examination of IOP, ocular fundus or
- any ocular or systemic conditions that may reduce OCT image quality (e.g., severe dry eye syndrome, visually significant cataract, limbal opacities, nystagmus, Parkinsonism, etc),
- Pregnant women or male or female younger than 18 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: OCT imaging of surgical/pharmacological/laser branch
to evaluate the effect on the conventional outflow pathway, and specifically on the Schlemm's canal (SC) anatomy in the surgical branch:
pharmacological branch-
laser branch-
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean SC (schlemm's canal) cross-sectional area and volume
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Correlation of changes with intraocular pressure (IOP) reduction
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-16-2797-OZ-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma
-
Imperial College Healthcare NHS TrustIRIDEX CorporationNot yet recruitingGlaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma Secondary | Glaucoma Traumatic | Glaucoma Uveitic
-
Wills EyeIOP OphthalmicsTerminatedPrimary Open Angle Glaucoma | Neovascular Glaucoma | Uveitic Glaucoma | Pseudoexfoliation Glaucoma | Primary Angle Closure Glaucoma | Pigmentary Glaucoma | Traumatic GlaucomaUnited States
-
Centre hospitalier de l'Université de Montréal...CompletedGlaucoma | Glaucoma, Open-Angle | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma and Ocular Hypertension | Glaucoma, Uncompensated | Glaucoma SecondaryCanada
-
Pro Top & Mediking Company LimitedCompletedOpen Angle Glaucoma | Neovascular Glaucoma | Angle Closure Glaucoma | Uveitis Glaucoma | Young Age Glaucoma | High Risk PatientEstonia
-
Sanoculis LtdCompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaIsrael
-
Bausch & Lomb IncorporatedNicOx Inc.CompletedPrimary Open Angle Glaucoma | Ocular Hypertension | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaUnited States
-
Sensimed AGCompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaFrance
-
Wills EyeOptovueCompletedPrimary Open-angle Glaucoma | Normal Tension Glaucoma | Glaucoma; DrugsUnited States
-
Ivantis, Inc.CompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaUnited States
-
iSTAR MedicalInternational Drug Development InstituteActive, not recruitingGlaucoma, Open-Angle Glaucoma EyeIndia, Panama
Clinical Trials on Optical coherence tomography imaging
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedCerebral AneurysmUnited States
-
University of California, IrvineBeckman Laser Institute University of California IrvineWithdrawnDisorder of Pleura and Pleural CavityUnited States
-
Apollo Medical Optics, LtdRecruitingSkin Cancer | Skin LesionGermany
-
Massachusetts General HospitalCompletedNon-Melanoma Skin Cancer (NMSC)United States
-
Assiut UniversityCompleted
-
Massachusetts General HospitalMassachusetts Eye and Ear InfirmaryNot yet recruitingHealthyUnited States
-
Jesse Brown VA Medical CenterUnknownPercutaneous Coronary Intervention | Optical Coherence Tomography | In-stent Coronary Artery RestenosisUnited States
-
Samsung Medical CenterCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedTransitional Cell Carcinoma of Urinary TractNetherlands
-
Duke UniversityTerminatedImage, BodyUnited States